Barak Eilam - NICE Chief Officer
| NCSYF Stock | USD 169.00 5.06 2.91% |
Executive
Mr. Barak Eilam serves as Chief Executive Officer at Nice Ltd since April 30, 2014. His work experience includes the following roles President of NICE American division, NICEs Head of Sales and General Manager of the Enterprise Group in the Americas, Founder and General Manager of NICE Interaction Analytics Global Business Unit, held a variety of Executive Positions within NICE Product Development, Product Management and Sales units and Officer for an elite intelligence unit within Israel Defense Forces. He holds a Bachelor of Engineering degree in Electrical Electronics Engineering from Tel Aviv University. since 2014.
| Age | 47 |
| Tenure | 10 years |
| Phone | 972 9 775 3151 |
| Web | https://www.nice.com |
NICE Management Efficiency
The company has return on total asset (ROA) of 0.0433 % which means that it generated a profit of $0.0433 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0863 %, meaning that it generated $0.0863 on every $100 dollars invested by stockholders. NICE's management efficiency ratios could be used to measure how well NICE manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Alisha Jerauld | Merit Medical Systems | N/A | |
| Sabrina Ellis | 51 | ||
| Brian JD | Merit Medical Systems | 63 | |
| Ricardo Alvarez | Merit Medical Systems | N/A | |
| Zenghui Cao | Weibo Corp | 46 | |
| Doniel Sutton | 50 | ||
| DeAnna Osteen | Weyco Group | N/A | |
| Wanjiku JD | 53 | ||
| Sarah Comstock | Merit Medical Systems | N/A | |
| Wen Li | Weibo Corp | N/A | |
| Matt Madrigal | N/A | ||
| Jeremy King | 55 | ||
| Brian Lloyd | Merit Medical Systems | 63 | |
| Jeff Douglass | Weyco Group | 42 | |
| Malik Ducard | 51 | ||
| Yun Lee | Franklin Wireless Corp | 63 | |
| Julia Donnelly | 41 | ||
| Bill Watkins | N/A | ||
| Tse Yang | 47 | ||
| Christine Flores | 45 | ||
| Wanjiku Walcott | 53 | ||
Management Performance
| Return On Equity | 0.0863 | |||
| Return On Asset | 0.0433 |
NICE Leadership Team
Elected by the shareholders, the NICE's board of directors comprises two types of representatives: NICE inside directors who are chosen from within the company, and outside directors, selected externally and held independent of NICE. The board's role is to monitor NICE's management team and ensure that shareholders' interests are well served. NICE's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, NICE's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Shiri Neder, Ex HR | ||
| Beth Gaspich, Chief Officer | ||
| Yaron Hertz, President-NICE Americas | ||
| John OHara, President-NICE EMEA | ||
| Craig Costigan, Chief Actimize | ||
| Barak Eilam, Chief Officer | ||
| Tali MirskyLachman, Vice President General Counsel, Secretary | ||
| Paul Jarman, CEO of inContact | ||
| Barry Cooper, Pres Division | ||
| Christopher Wooten, Executive Vice President-Vertical Markets |
NICE Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is NICE a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0863 | |||
| Return On Asset | 0.0433 | |||
| Profit Margin | 0.12 % | |||
| Operating Margin | 0.15 % | |||
| Current Valuation | 11.93 B | |||
| Shares Outstanding | 63.53 M | |||
| Shares Owned By Institutions | 12.10 % | |||
| Price To Earning | 67.11 X | |||
| Price To Book | 4.45 X | |||
| Price To Sales | 5.97 X |
Currently Active Assets on Macroaxis
Other Information on Investing in NICE Pink Sheet
NICE financial ratios help investors to determine whether NICE Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in NICE with respect to the benefits of owning NICE security.